Cargando…

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China

Patients with antiretroviral therapy interruption have a high risk of virological failure when re-initiating antiretroviral therapy (ART), especially those with HIV drug resistance. Next-generation sequencing may provide close scrutiny on their minority drug resistance variant. A cross-sectional stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Miaomiao, Liang, Shujia, Zhou, Chao, Chen, Min, Liang, Shu, Liu, Chunhua, Zuo, Zhongbao, Liu, Lei, Feng, Yi, Song, Chang, Xing, Hui, Ruan, Yuhua, Shao, Yiming, Liao, Lingjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996606/ https://www.ncbi.nlm.nih.gov/pubmed/33668946 http://dx.doi.org/10.3390/pathogens10030264

Ejemplares similares

Early antiretroviral therapy on reducing HIV transmission in China: strengths, weaknesses and next focus of the program
por: Liu, Pengtao, et al.
Publicado: (2018)

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
por: Zuo, Zhongbao, et al.
Publicado: (2016)

Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018)

HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study
por: Chen, Yi, et al.
Publicado: (2023)

Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy
por: Cao, Zhiqiang, et al.
Publicado: (2020)

Relationship Between Drug Resistance and Death in HIV-Infected Patients Receiving Antiretroviral Therapy — 7 PLADs, China, 2010−2019
por: Zhang, Tianhao, et al.
Publicado: (2021)

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022)

Prevalence of Transmitted HIV drug resistance in antiretroviral treatment naïve newly diagnosed individuals in China
por: Zhao, Shuai, et al.
Publicado: (2018)

Low Virologic Failure and Drug Resistance among HIV-Infected Patients Receiving Hospital-Based ART While Care and Outreach through Community in Guangxi, China
por: Liang, Shujia, et al.
Publicado: (2015)

Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008–2012: a prospective cohort study
por: Kan, Wei, et al.
Publicado: (2017)

Genetic network analysis of human immunodeficiency virus sexual transmission in rural Southwest China after the expansion of antiretroviral therapy: A population-based study
por: Chen, Jin, et al.
Publicado: (2022)

Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China
por: Liu, Lei, et al.
Publicado: (2019)

Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China
por: Liu, Pengtao, et al.
Publicado: (2022)

Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study
por: Cao, Pi, et al.
Publicado: (2018)

HIV drug resistance in patients in China’s national HIV treatment programme who have been on first-line ART for at least 9 months
por: Liu, Pengtao, et al.
Publicado: (2020)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
por: Liao, Lingjie, et al.
Publicado: (2013)

HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China
por: Leng, Xuebing, et al.
Publicado: (2014)

Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
por: Xu, Xiaoshan, et al.
Publicado: (2021)

Treatment outcomes of initial differential antiretroviral regimens among HIV patients in Southwest China: comparison from an observational cohort study
por: Kang, Ruihua, et al.
Publicado: (2019)

HIV-1 Disease Progression and Drug Resistance Mutations among Children on First-Line Antiretroviral Therapy in Ethiopia
por: Getaneh, Yimam, et al.
Publicado: (2023)

Incidence and Associated Factors of HIV Drug Resistance in Chinese HIV-Infected Patients Receiving Antiretroviral Treatment
por: Xing, Hui, et al.
Publicado: (2013)

Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China
por: Liu, Pengtao, et al.
Publicado: (2017)

Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study
por: Tang, Zhenzhu, et al.
Publicado: (2017)

The development of drug resistance mutations K103N Y181C and G190A in long term Nevirapine-containing antiviral therapy
por: Wang, Yuncong, et al.
Publicado: (2014)

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012
por: Wang, Jing, et al.
Publicado: (2014)

The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China
por: Gan, Mengze, et al.
Publicado: (2021)

Spatiotemporal Patterns of CRF07_BC in China: A Population-Based Study of the HIV Strain With the Highest Infection Rates
por: Gan, Mengze, et al.
Publicado: (2022)

Immune reconstruction effectiveness of combination antiretroviral therapy for HIV-1 CRF01_AE cluster 1 and 2 infected individuals
por: Li, Kang, et al.
Publicado: (2021)

Impacts of HIV-1 Subtype Diversity on Long-Term Clinical Outcomes in Antiretroviral Therapy in Guangxi, China
por: Jiang, He, et al.
Publicado: (2022)

Treatment Outcomes of HIV Infected Children After Initiation of Antiretroviral Therapy in Southwest China: An Observational Cohort Study
por: Zeng, Xiaoliang, et al.
Publicado: (2022)

Efficacy and HIV drug resistance profile of second-line ART among patients having received long-term first-line regimens in rural China
por: Wang, Jing, et al.
Publicado: (2015)

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018
por: Hao, Jingjing, et al.
Publicado: (2021)

Trends of HIV subtypes and phylogenetic dynamics among young men who have sex with men in China, 2009–2014
por: Li, Zheng, et al.
Publicado: (2015)

HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients
por: Xing, Hui, et al.
Publicado: (2013)

Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China
por: Yan, Jing, et al.
Publicado: (2016)

Higher Risk of Mortality and Virologic Failure in HIV-Infected Patients With High Viral Load at Antiretroviral Therapy Initiation: An Observational Cohort Study in Chongqing, China
por: Zhou, Chao, et al.
Publicado: (2022)

The next generation of the World Health Organization's global antiretroviral guidance
por: Hirnschall, Gottfried, et al.
Publicado: (2013)

Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China
por: Su, Mingze, et al.
Publicado: (2018)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i4cja4asl2akjc812008d5ts2v